These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 17597314

  • 1. Use of microcalorimetry in determination of stability of enalapril maleate and enalapril maleate tablet formulations.
    Simoncic Z, Zupancic P, Roskar R, Gartner A, Kogej K, Kmetec V.
    Int J Pharm; 2007 Sep 05; 342(1-2):145-51. PubMed ID: 17597314
    [Abstract] [Full Text] [Related]

  • 2. Stability and in vitro release profile of enalapril maleate from different commercially available tablets: possible therapeutic implications.
    Lima DM, dos Santos LD, Lima EM.
    J Pharm Biomed Anal; 2008 Aug 05; 47(4-5):934-7. PubMed ID: 18472382
    [Abstract] [Full Text] [Related]

  • 3. Design and evaluation of a new formulation of enalapril maleate tablet.
    Bibi R, Naqvi BS, Shoaib MH, Rahim N.
    Pak J Pharm Sci; 2011 Apr 05; 24(2):211-5. PubMed ID: 21454172
    [Abstract] [Full Text] [Related]

  • 4. Proposal of a new degradation mechanism of enalapril maleate and improvement of enalapril maleate stability in tablet formulation with different stabilizers.
    Chen J, Zhang LH, Xu RJ, Bu NJ, Zhang L.
    Pharmazie; 2014 Apr 05; 69(4):277-80. PubMed ID: 24791591
    [Abstract] [Full Text] [Related]

  • 5. Stability of extemporaneous enalapril maleate suspensions for pediatric use prepared from commercially available tablets.
    Sosnowska K, Winnicka K, Czajkowska-Kośnik A.
    Acta Pol Pharm; 2009 Apr 05; 66(3):321-6. PubMed ID: 19645333
    [Abstract] [Full Text] [Related]

  • 6. Enalapril maleate polymorphs: instability of form II in a tablet formulation.
    Eyjolfsson R.
    Pharmazie; 2002 May 05; 57(5):347-8. PubMed ID: 12061263
    [No Abstract] [Full Text] [Related]

  • 7. Kinetics of degradation of enalapril maleate in dosage forms.
    Stanisz B.
    Acta Pol Pharm; 2004 May 05; 61(6):415-8. PubMed ID: 15794332
    [Abstract] [Full Text] [Related]

  • 8. Enalapril maleate form II: stabilization in a tablet formulation.
    Eyjolfsson R.
    Pharmazie; 2003 May 05; 58(5):357. PubMed ID: 12779058
    [No Abstract] [Full Text] [Related]

  • 9. Stability of new potential ACE inhibitor in the aqueous solutions of different pH.
    Roskar R, Simoncic Z, Gartner A, Kmetec V.
    J Pharm Biomed Anal; 2009 Feb 20; 49(2):295-303. PubMed ID: 19135817
    [Abstract] [Full Text] [Related]

  • 10. Effect of the drug-matrix on the stability of enalapril maleate in tablet formulations.
    Al-Omari MM, Abdelah MK, Badwan AA, Jaber AM.
    J Pharm Biomed Anal; 2001 Jul 20; 25(5-6):893-902. PubMed ID: 11377072
    [Abstract] [Full Text] [Related]

  • 11. The use of microcalorimetry and HPLC for the determination of degradation kinetics and thermodynamic parameters of Perindopril Erbumine in aqueous solutions.
    Simoncic Z, Roskar R, Gartner A, Kogej K, Kmetec V.
    Int J Pharm; 2008 May 22; 356(1-2):200-5. PubMed ID: 18304767
    [Abstract] [Full Text] [Related]

  • 12. Physicochemical stability of captopril and enalapril extemporaneous formulations for pediatric patients.
    Casas M, Álvarez J, Lucero MJ.
    Pharm Dev Technol; 2015 May 22; 20(3):271-8. PubMed ID: 24279906
    [Abstract] [Full Text] [Related]

  • 13. The application of VIS spectrophotometric determination of enalapril maleate in substance, in tablets and estimation of ester group stability.
    Stanisz B.
    Acta Pol Pharm; 1999 May 22; 56(6):431-4. PubMed ID: 10715888
    [Abstract] [Full Text] [Related]

  • 14. Stability of an alternative extemporaneous captopril fast-dispersing tablet formulation versus an extemporaneous oral liquid formulation.
    Pabari RM, McDermott C, Barlow J, Ramtoola Z.
    Clin Ther; 2012 Nov 22; 34(11):2221-9. PubMed ID: 23149007
    [Abstract] [Full Text] [Related]

  • 15. Enhanced intestinal permeability and oral bioavailability of enalapril maleate upon complexation with the cationic polymethacrylate Eudragit E100.
    Ramírez-Rigo MV, Olivera ME, Rubio M, Manzo RH.
    Eur J Pharm Sci; 2014 May 13; 55():1-11. PubMed ID: 24456933
    [Abstract] [Full Text] [Related]

  • 16. Influence of different types of commercially available microcrystalline cellulose on degradation of perindopril erbumine and enalapril maleate in binary mixtures.
    Vehovec T, Gartner A, Planinšek O, Obreza A.
    Acta Pharm; 2012 Dec 13; 62(4):515-28. PubMed ID: 23333887
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Simultaneous quantification of enalapril and enalaprilat in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study.
    Lu S, Jiang K, Qin F, Lu X, Li F.
    J Pharm Biomed Anal; 2009 Jan 15; 49(1):163-7. PubMed ID: 19046843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.